Rather unexpectedly, major histocompatibility complex class II-deficient mice have a significant population of peripheral CD4 + T lymphocytes. We have investigated these cells at the population and clonal levels. CD4 + T lymphocytes from class II-deficient animals are thymically derived, appear early in ontogeny, exhibit the phenotype of resting memory cells, are potentially functional by several criteria, and have a diverse T cell receptor repertoire. They do not include substantially elevated numbers of NKI.1 § cells. Hybridomas derived after polyclonal stimulation of the CD4 + lymphocytes from class II-deficient animals include a subset with an unusual reactivity pattern, responding to splenocytes from many mouse strains including the strain of origin. Most members of this subset recognize the major histocompatibllity complex class Ib molecule CD1; their heterogenous reactivities and T cell receptor usage further suggest the involvement of peptides and/or highly variable posttranslational modifications.
M
ost CD4 + T cells depend on an interaction with the MHC class II molecules expressed on thymic stroma to complete differentiation. As a consequence, mice that lack the conventional class II molecules (II ~ mice) 1 have a drastic reduction in the number of mature CD4 + T cells in the thymus and peripheral lymphoid organs (1) (2) (3) . Unexpectedly, though, a small population of CD4 + T cells was detected in the spleen and lymph nodes of these animals. This population did not appear to result from nonspecific "leakage" because the cells had atypical properties: they expressed markers reminiscent of memory cells and were preferentially localized in the B cell areas of lymphoid organs.
The existence ofCD4 + T cells in II ~ mice contradicts previous dogma on positive selection, which states that CD8 + cells result from a TCtL/MHC class I molecule engagement in the thymus and react in the periphery to antigen presented by class I molecules, while CD4 + cells emerge after a TCR/class II interaction and have class II-restricted antigen reactivities (reviewed in reference 4). Since the CD4 + cells in the II ~ mice could not have been selected on 1Abbreviations used in this paper: BrdU, bromodeoxyuridine; ~2m ~ J32 microglobulin-deficient mice; Ii ~ invariant chain deficient; II ~ mice, mice that lack the conventional class II molecules; TAP, transporter associated with antigen processing. conventional class II molecules, several questions arose: When and where are these cells generated? Does their cell surface phenotype show other atypical features? Are they functional? If so, what ligands do they recognize? Here, we address these questions at the population and clonal levels. Besides determining some important general properties of the peripheral CD4 + T cell population in II ~ mice, we describe an interesting set of hybridomas derived from this population.
Materials and Methods
Mice. II ~ mice (1), originally on a mixed C57BL/6J 036) X 129 background, were mostly from the fifth to eighth generation backcross to B6; invariant chain-deficient mice (Ii ~ (5) were on a mixed B6 • 129 background; B cell-deficient mice (6) , were bred onto the nonobese diabetic (NOD) genetic background; ]32-microglobulin-deficient mice ([32m ~ (7) were on a B6 • 129 background. Most mice were maintained in specific pathogen-flee conditions at the Centre de Selection d'Animaux de Laboratoire (Orleans, France). DBA/2J, 129, and NOD/Lt mice were bred in our animal facilities. The BALB.Mls ~ congenic strain carries the Mls a locus (Mtv-7) of DBA/2 mice on the BALB/c genetic background and was obtained thanks to 1K. Zinkernagel (Institute for Experimental Immunology, Ziirich, Switzerland) and IK. McDonald (Ludvig Institute for Cancer IKesearch, Epalinges, Switzerland). Mice deficient in the transporter Intrathymic FITC Injections. Intrathymic FITC injections were performed as described (19) . Both thymic lobes of the 5-wk-old mice were injected with 10 txl of 1 mg/ml FITC in PBS. 24-36 h later, thymus and lymph node cells were prepared and stained with c~-CI)4 and c~-CD8 reagents. The level of FITC label on thymocytes was analyzed to evaluate the efficiency of intrathymic injection, and only successfully injected mice were analyzed further. Events of each sample were collected ungated, and gated for CD4 + and CD8 + cells (at least 50-100 X 103 events per gated population), and analyzed for frequencies of FITC + cells. Cells from noninjected or intrathorax-injected (19) mice were used as negative controls.
Bromodeoxyuridine (BrdU) Labeling. 0.8 mg BrdU in PBS was injected intraperitoneally into mice every 12 h for 2 d. 12 h after the last injection, mice were killed and lymph node cells were prepared. The cells were fixed first in 70% EtOH, then 1% paraformaldehyde, and stained with CD4-PE and CD8-biotin followed by streptavidin-cytochrome, then stained to detect incorporated BrdU after a modification (20) of (21) using anti-BrdU-FITC (Becton Dickinson).
T Cell Activation. Spleen and lymph node cells were pooled and depleted of B cells by panning with polyclonal rabbit antimouse Ig antibodies coated on plastic petri dishes, and then depleted of CD8 + cells after labeling with CD8-biotin and streptavidin-magnetic beads using the MACS (magnetic cell separation) magnet (Miltenyi Biotec, Bergish-Gladbach, Germany), following the manufacturers instructions. The cells were then sorted twice for CD4 + cells, resulting in a >95% pure population. In some experiments, the depletion steps were omitted. The sorted CD4 + cells were stimulated at 1.5-3 X 104 cells per well in anti-CD3-coated (KT3 antibody coated at 5 Ixg/ml or as indicated) round-bottom, 96-well plates in Hepes-buffered RPMI 1640 medium containing glutamine supplemented with 10% FCS, 20 IxM 2-ME, 1 mM Na-pyruvate, and penicillin/streptomycin. 2 d later, the wells were pulsed with 1 IxCi [3H]TdR and were hatvested 16-20 h later. The amount of incorporated [3H]TdR was measured in a gas scintillation Matrix Direct Beta Counter 9600 (Packard Instrument Co., Meriden, CT) with a counting efficiency of 25% compared with liquid scintillation counting.
AnalFsis of Lymphokine Production. At the indicated times during in vitro stimulation, supernatants were harvested and dilutions were added to 104 CTLL cells per well. After 24 h of culture, wells were pulsed with 1 I.LCi [3H]TdR for 3-6 h and harvested. IL-4 and IFN-y were quantitated in an ELISA using the BVl)4-11)11 (anti-IL-4) or AN-18 (anti-IFN-y) antibodies to coat 96-well plates, followed by incubation with dilutions of culture supernatant. Bound lymphokine was revealed by a biotinylated second IL-4 (BVD6-24G2)-or IFN-y (R4-GA2)-specific antibody, streptavidin-alkaline phosphatase and the euzyme substrate (104 phosphatase substrate tablets; Sigma hnnmnochemicals, St. Lonis, mo). TCR Sequencing. PCP,, sequencing of TCR-{~ and -13 cl)NAs from sorted populations of CD4 § cells or from hybridomas was perfornled after amplifcation with degenerate V{* and V13 primers as detailed previously (27) . For Vot14-specific amplifications, the V region primer was 5'-GTCCTGACCTCGCATGCGA-CAACCACTTAAGGTGGTTC.
Results

A Peripheral Population of CD4 + T Cells Independent OF Conventional Class I and 11
Molecules. In adult II ~ mice, 5-15% of the usual number ofCD4 + cells can be found in the spleen and lymph nodes (Fig. 1 A) , and 90% of these express the ot]3 TCR (references 1-3 and data not shown). As previously discussed (I), the simplest explanation for such cells is that they were positively selected on MHC class l molecules. To test this, we crossed the II ~ line with mice deficient in class I expression because of a disrupted 132m gene (7) . The double mutants had a peripheral population oFCD4 + cells similar in numbers and phenotype to that of II ~ animals ( Fig. 1 and data 
Population Dynamics of the CD4 + T Cells in 11 ~ Mice.
To study the ontogeny of this unusual population, we followed the appearance of CD4+CD3 + cells in the spleen and mesentefic lymph nodes of mutant and control animals from the 1st d after birth. A CD4+CD3 + population was clearly detectable in the two organs of both types of mice during the 1st wk of life. In both cases, the number of CD4+CD3 + cells increased N10-fold during the subsequent 2 wk (quantitated in the spleen; Fig. 2 ). Once established, the II ~ CD4 + population was maintained without changing size, even in mice >1 yr old (not shown).
We next sought to determine whether the CD4 + cells in II ~ mice originate in the thymus (19) wk-old mutant and control mice were marked in situ by intrathymic injection of FITC. 30 h later, lymph nodes were analyzed for the presence of thymus-derived, FITClabeled cells (Fig. 3 A) . CD4 + and CD8 + cells from control animals and CD8 + cells from mutants were all labeled to a similar extent. FITC + early thymic emigrants were also readily detectable among lymph node CD4 + cells in II ~ mice, albeit at frequencies slightly lower than that of control CD4 + and CD8 + cells. The rate of export of CD4 + cells from the II ~ thymus was ,'ol/50 of the control thymus, allowing an approximation of 1-2 X 104 cells per d (19) .
To determine the proportion of cycling cells in the established CD4 § population, we exposed control and mutant mice to BrdU confnously for 48 h. As for the control II + (MHC class II-positive) mice, only a small proportion of lymph node CD4 + cells in II ~ mice had incorporated BrdU during the labeling period (5-11%; see Fig. 3 B) , indicating that only a minor fraction was actively dividing.
Altogether, these data indicate a stable population of CD4 + T cells in II ~ mice. Its thymic input rate and proliferative turnover rate are not markedly different from those exhibited by the CD4 + T cells of wild-type animals.
Cell Surface Marker Profiles. The initial description of CD4 + T cells in II ~ mice indicated atypical cell surface antigen profiles: reduced levels of CD3/TCR and high levels of CD44. We extended this phenotypic analysis by using several additional antibodies that detect T cell differentiation and activation markers (Fig. 4) .
The cells expressed normal levels of the T cell markers CD2 and CD28 (Fig. 4) , as well as CD5 and Thy-1 (not shown). In contrast to control CD4 + T cells, 75-80% of the CD4 + cells from mutant mice had a phenotype characteristic of memory cells (for review, see reference 28): CD45RB l~ CD62L-and increased levels of CD54 (ICAM-1) and CD11a (LFA-1). Nevertheless, the majority of cells were in a resting state as evidenced by generally low CD69 and CD25 expression. The fraction of CD69-expressing CD4 + cells in II ~ mice was somewhat elevated (20-30%, compared with 5-10% in II + CD4 + cells), but still represented only a minority of the population, consistent with the cell cycle analysis mentioned above. An unusual population of thymocytes and peripheral T lymphocytes has recently been described. These cells are positive for the NKI.1 marker (29, 30) , their selection is 132m dependent (31) (32) (33) (34) , and they preferentially express certain V(x and VI3 segments (29, 30, (35) (36) (37) . The frequency of CD4 + cells expressing the NKI.1 marker was higher in lI ~ than II + mice: 15-25% of the CD4 + cells in spleen or lymph node in II ~ mice were positive, while only 2-6% of control CD4 + cells were. However, given that II ~ mice have 10-20-fold fewer CD4 + cells than II + mice, the absolute number of NKI.1 + CD4 + cells in both animals was similar, a finding in agreement with previous results (32) (33) (34) . We conclude, therefore, that the NKI.1 + population is only a subset of the CD4 + cells in II ~ mice. This point is further substantiated by the broad TCR repertoire ofCD4 + cells in II ~ mice (see below).
Functional Potential. The next priority was to establish
to what extent the CD4 + T cells from II ~ mice function like normal CD4 T cells. Purified CD4 + cells from both mutant and control animals proliferated vigorously in response to plate-bound anti-CD3 (Fig. 5 A) or staphylococcal enterotoxin B in the presence of splenic APCs (not shown), the II ~ CD4 + cells often slightly better. Anti-CD3 stimulation also led to upregulation of the early activation markers CD69 and CD25 on both mutant and control CD4 + cells (not shown).
Stimulation with anti-CD3 induced the CD4+cells from II ~ mice to produce similar amounts of IL-2 ( Fig. 5 B) , and more IL-3 (not shown), IL-4 , and IFN-',/ (Fig. 5 C) than CD4 + cells from control mice. The main difference concerned IL-4, quite abundant in mutant CD4 + cells but very low to undetectable in wild-type cells, as expected for naive cells. Mutant-derived CD4 + cells secreted cytokines already at 4 h; in both cases, the levels of IL-4 and IFN-~/in the supematant increased until day 2 (Fig. 5 C) . Strikingly, the IL-4/IFN-~/ratio produced by the CD4 + cells derived from II ~ animals was several-fold higher than that of control CD4 + cells. Furthermore, when Th activity oflI ~ and control CD4 + cells was compared in a nonspecific B cell help assay in vitro, purified CD4 + cells from mutant and control mice induced B cell proliferation to similar levels (not shown).
Together, these findings argue that the CD4 + T cells in II ~ mice are functionally similar to control CD4 + cells but they secrete different ratios oflymphokines when activated.
TCR Repertoire. The TC1K repertoire displayed by CD4 + cells from II ~ mice was first investigated by quantitating expression of various V[3s and VoLs on lymph node cells. Our initial studies (1), using conventionally housed mice at earlier stages of the backcross to B6, had shown some variability in V~ usage between individual II ~ mice. This variability was not confirmed in the present study (Table 1). CD4 + cells in II ~ mice made broad use of V[3 segments, exhibiting an overall pattern comparable with that of CD4 + cells in control littermates. Some differences did emerge, however. V[35 and V[39 are much rarer in CD4 + than CD8 + cells of normal mice (Table 1 and reference 38); these V[3s were found in greater proportions in CD4 + cells of II ~ animals. Conversely V134 is overrepresented in CD4 + vs CD8 + cells of normal mice (Table 1 and reference 39), and was used at a low frequency in CD4 + cells from It ~ animals. There are also a few peculiarities specific represent a diverse population of potentially functional cells, it was of interest to identify their restricting (and possibly selecting) elements. We tried to derive allo-or autoreactive hybridomas on the grounds that such reactivities might give us a clue to their natural restricting elements, much as MHC class II-directed allo-and autoreactive cells from normal mice reflect the class II restriction of the bulk of the CD4 + cells. To generate a panel of hybridomas, we purified CD4 + T cells from several II ~ and II + littermates, stimulated them with anti-CD3, and fused them with TCR-~x-]3-BW5147 cells. We then challenged the hybridomas with splenocytes from several mouse strains, differing at MHC, minor histocompatibility, and/or endogenous murine tumor virus loci.
As indicated in Fig. 6 , very few of the hybridomas from II + littermates responded to any spleen cell stimuli, save for a scattered few whose reactivities correlated with H-2 haplotype (e.g., XII44 and XIV18, reactive to H-2 a) or with endogenous murine tumor virus genes (e.g., XII49 and XIV50, Mlsa); only one (X17) was autoreactive (Ab-reactive). The reactivity pattern of the hybridomas derived from II ~ mice was very different: while there was no activation when they were cultured alone, >10% responded to syngeneic II ~ spleen cells in the absence of any added antigen. M1 of these autoreactive hybridomas, which originated from several mice, also displayed a broad reactivity pattern, since all but two were stimulated by spleen cells from every mouse strain tested. This suggested a nonpolymorphic target, clearly distinct from classical MHC class I and II molecules.
Recognition of Class l-like Ligands by the Autoreactive
Hybridomas. To investigate the nature of the nonconventional ligand(s) recognized by the polyreactive hybridomas derived from mutant mice, we selected 11 for further analysis. Although a population of CD4 + T cells was present in [32m~ ~ double-mutant animals, this did not entirely rule out peripheral reactivity to MHC molecules, and the nonpolymorphic nature of the ligands was reminiscent of nonclassical MHC molecules. We therefore considered the possibility that such molecules, either class II-or class Ilike, might serve as ligands. Their expression might well depend, for the former, on the Ii involved in trafficking of conventional MHC class II molecules, or for the latter, on ]32m. We thus tested the panel of hybridomas with spleen 998 cells from mutant Ii ~ or [32m ~ mice (5, 7). All of the hybridomas were well stimulated by Ii-deficient APCs (not shown), while Ii ~ APCs were not recognized by control Al'-reactive hybridomas. On the other hand, 6 of the 11 hybridomas did not respond to splenocytes from 132m ~ mice (Fig. 7) . This encouraged us to pursue the idea that nonpolymorphic class I-like molecules are recognized by the autoreactive hybridomas from II ~ mice.
Qa-1 Recognized by One of the Autoreactive Hybridomas.
The reactivity of the ]32m-dependent hybridoma VII11 appeared to correlate with the expression of the b allele of the class Ib molecule Qa-1 (Fischer-Lindahl, K., personal communication). For example, as shown in Fig. 6 , splenocytes from the strains C3H/He (H-2 k) and B10.S (H-2 ~) both express Qa-1 b and elicited a response, while those from B10.BR. (H-2 k) and SJL (H-2 S) show Qa-1 a and did not. This correlation was extended by using a pair of congenic strains. B6 mice express the b allele of Qa-1, while B6.Tla" animals are congenic for the T region, including the Qa-I encoding T23 gene, and carry the Qa-P allele. B6 but not B6.Tla a spleen cells were well recognized by the VII11.1 hybridoma (not shown). Finally, we directly tested whether Qa-1 was being recognized by stimulating the VII 11.1 hybridoma with L cells transfected with the T2Y' gene (24).
The hybridoma responded specifically to transfectants expressing Qa-1 b, but not to mock transfected cells nor to cells transfected with other Ib genes (Fig. 8) .
CD1 Recognized by the Majority of the Autoreactive
Hybridomas. For the other autoreactive hybridomas, the reactivities depicted in Fig. 6 were too broad to give much clue as to the targets involved. We could exclude the class Ib molecule Qa-2, as the stimulating ligand(s), was found to be present on splenocytes of B10.M mice (not shown) that carry a deletion encompassing the genes encoding surface-bound Qa-2 (40) . Therefore, we tested the panel against a set of transfectants expressing other class lb molecules: the T region-encoded antigens TL (26), T22, and T10 (25) , and a molecule encoded outside the MHC, CD1 (Teitell, M., et al., manuscript submitted for publication).
Both the ]32m-dependent and -independent hybridomas were included in the screening because there is at least one example of a class Ib molecule that shows variable dependence on [32m for surface expression (41) . The results are presented in Fig. 8 . Strikingly, seven hybridomas, including two [32m-independent, specifically recognized transfectants expressing CDI.I; these reactivities could be detected with CD1.1-transfected 1KMA or L cells (not shown). nized by the CDl-reactive hybridomas were TAP dependent (representative examples are shown in Fig. 9 ). This was true whether or not their expression was dependent on [32m. The heterogeneity of the hybridomas was evaluated by a number of criteria, as summarized in Fig. 10 . TCR V region sequencing showed diverse usage of V[3 and Vc~ regions, with variable CDR3 lengths and amino acid compositions (not shown). It may be worth emphasizing that none of our CDl-reactive hybridomas expressed the invariant VJ314-JJ315 sequence characteristic ofNKl.l CD4 + cells (37) , as detemined by reverse transcription PCR with VI314-specific primers (not shown).
TAP-independent
Heterogeneity of the
Heterogeneity was more evident in the responses to stimulation by APCs from different mutant or inbred mouse strains. As mentioned above (Fig. 7) , two of the seven CDl-reactive hybridomas were capable of responding to APCs from [32m ~ mice. The txMT knockout mutation, which abrogates B cell development (6), prevented splenic APCs from stimulating two other hybridomas, indicating that B cells are necessary presenting cells in these instances. As already indicated in Fig. 6 , most of the hybridomas responded to all of the nonmutant common laboratory strains. Clone VIII82, however, reacted very poorly to APCs from BALB/c mice, even though B6 and BALB/c mice have essentially identical CDI.1 molecules and CD1.2 molecules that differ only by one amino acid (47, 48) . Finally, we tested the hybridomas against splenic APCs from various subspecies of Mus (Fig. 10) . Here again, the responses led to splits. These results clearly indicate that the CDl-specific hybridomas are heterogeneous and do not recognize one simple ligand.
Discussion
A Diverse but Distinct Population. Our analysis of the CD4 + T lymphocytes found in the periphery of II ~ mice indicated that these cells share many characteristics with the major CD4 + T lymphocyte subset found in normal animals. By several criteria, the dynamics of the two populations appeared similar: ontogeny, thymic input, and division rate.
Furthermore, the two seemed to have comparable functional potentials: they were stimulated to about the same degree with polyclonal reagents, secreted lymphokines, and they proliferated upon activation and provided "help" to B cells. Finally, both populations displayed a diverse repertoire of TCRs.
Nevertheless, the CD4 + population from II ~ mice displayed some special features. These cells localized preferentially to the B rather than T cell areas in the peripheral lymphoid organs (1) . Perhaps, most strikingly, the majority of them expressed cell surface markers reminiscent of resting memory cells, while in normal mice, only 10-20% of the CD4 + T lymphocytes show this phenotype. Also atypical was their capacity to produce high amounts of lymphokines, particularly IL-4, upon activation. Lastly, although the II ~ CD4 + cells, like their II + counterparts, displayed a diverse TCR repertoire, this repertoire did exhibit some particularities, notably altered levels of certain VJ3s and a dearth of Vex2 + receptors.
Altogether, one is left with the impression of a population sharing many features with the normal CD4 + T lymphocyte population, yet not identical to it. We do not formally know whether these cells are a peculiarity of II ~ mice. They have not so far been identified in normal mice but could just be masked by the bulk CD4 + T cell population.
The CD4 + cells from II ~ mice were also distinct from the unusual population of NKI.1 + mature CD4+8 and CD4-8-thymocytes and peripheral T lymphocytes discovered several years ago (35, 36) . An enriched proportion of these cells displays V[38 + TCRs, and almost all of them exhibit an invariant TCR-ot chain, V[314-J15 (29, 30, (35) (36) (37) . The majority shows a cell surface phenotype similar to memory cells, particularly high levels of CD44 + expression (29) . NK1.1 + lymphocytes are the major lymphokine-producing cells in the thymus (49) (50) (51) , and peripheral NKI. Figure 10 . Heterogeneity of the CDl-specific hybridomas. Results were compiled from several sets of experiments. Expression of TCR V segments was determined by sequencing of the TCR-cl and -13 chains and/or staining. For two hybridomas, two in-flame ix chain sequences were found. A second TCR-o~ sequence was found for VII49 with an out of flame rearrangement. Surface expression of the V segment (K chain for VIII24 and VII182, [3 chain for VIII24, VII68, and VIII57) was verified by staining with V region-specific antibodies. V~9 expression of VII49 was determined by staining only. The VII57 V~x sequence is so far undescribed, but was tentatively assigned Vix since it had the highest homology (~80%) to members of this Vix family. The CDl-specific hybridomas were stimulated with splenic APCs from ~32m ~ B cell~deficient mice (I.LmT~ wild-type BALB/c mice, or several subspecies of Mus. Black boxes, positive reactions; empty boxes, no reaction; nd, not determined. altered our strategy, therefore, this time preparing a large number ofhybridomas after in vitro anti-CD3 activation of purified CD4 + cells from II ~ and II + mice, and challenging them with splenocytes from a panel of mouse strains. We could identify hybridomas derived from both types of mice that exhibited anti-MHC or anti-Mls reactivities. Only in the case of II ~ mice, however, did we observe a significant percentage of hybridomas that were both auto-and polyreactive.
Focusing on 11 with this unusual pattern of reactivity, we explored their specificities using splenocytes from congenic and mutant mouse strains and cells transfected with MHC class I molecules. Many of the hybridomas reacted specifically to class Ib molecules: one recognized Qa-1, seven saw CD1, and three recognized unidentified ligands, all expressed independently of [32m.
One is led to ask whether reactivity to nonclassical class I molecules reflects the restricting specificity of the majority of the CD4 + cells in II ~ mice, or is just a feature of a minor component of the population. Clearly, a large percentage of the autoreactive hybridomas recognized class Ib molecules. But most of them did not show reactivity to any of the APCs with which they were challenged. It is certainly possible that most of the CD4 + cells in II ~ mice are restricted by class Ib molecules, including CD1, but that they react to these molecules in forms that are not present on splenocytes, e.g., in association with different ligands like peptides or lipids. The autoreactive clones could just represent the higher affinity fraction of a population of Ibrestricted cells, much like rare class II-autoreactive cells in wild-type mice betray the large class II-restricted population.
CDI Recognition. Several recent findings have provoked interest in the class Ib molecule CD1. It is the only antigen-presenting Ib molecule known to have been conserved through evolution, and the homology between species is high (53) . Interestingly, CD1 exhibits features similar to both class I and class II MHC molecules. On the one hand, the intron/exon structure of the CD1 gene and the corresponding domain structure of the protein are like those of standard class I genes and molecules, and there is sequence homology between the or3 domain of CD1 and the same domain of classical class I molecules (54) . On the other hand, the or3 domain of CD1 has a similar degree of sequence homology with the [32 domain of class II molecules (54) , and CDI's cell-type distribution (41, 53, 55) and antigen presentation pathway appear more characteristic of class II molecules (44) . While murine CDl-restricted T cells have not yet been described, several human T cell clones recognizing CD1 have been isolated (44, (56) (57) (58) (59) : they are CD4-CD8-cells expressing either an ot[3 or y8 TCFZ. In one case, the presented antigen was of a novel type, mycolic acid, a unique lipid component of the mycobacterial cell wall (46) . This observation reopens the question of whether CD1 can bind peptides at all, a question previously raised because sequence information suggested a very different structure in the ligand-binding region (60) and because surface expression of CD1 appeared independent of TAP molecules (44, 45) . Indeed, TAP independence of murine CDI was confirmed, at the functional level in our assay, and it has recently been demonstrated in transfectants (Teitell, M., et al., manuscript submitted for publication).
Our findings add several new features to the emerging portrait of this intriguing class Ib molecule. First of all, we found that CD4 + T cells can also show CD1 reactivity. This may indicate that CD4 can serve as a coreceptor for CD1 recognition by direct CD1-CD4 contact. It has been demonstrated that CD8 can bind CD1 (Teitell, M., et al., manuscript submitted for publication), but the CD1 (x3 domain similarity to both class I and II molecules may allow promiscuous binding to either coreceptor molecule. Secondly, we observed significant heterogeneity in the reactivity patterns and TC1L usages of the different CDl-reactive hybridomas. This suggests that the target ligand may be composed of more than just the CD1 molecule itself, perhaps including peptides, lipids (46) , or other posttranslational modifications. It seems unlikely, though, that a lipid moiety would be recognized by our hybridomas because the polymorphism we detect between very related Mus subspecies would be difficult to account for in this way. Finally, since the CDl-reactive hybridomas derive from the small CD4 + population in II ~ mice, we have the means to dissect their function in vivo. Already, we know that they do not mount a response to several multiepitope protein antigens and are incapable of providing full B cell help, evidenced by a total lack of germinal centers in II ~ mice, no matter how or how much one stinmlates them (1) . We are left with several pressing questions: How are these autoreactive cells rendered and maintained innocuous in mice? What agents are capable of provoking them? What is the functional correlate of their impressive capacity to produce IL-4? What cells and molecules are responsible for their selection/expansion?
